A new administration is running things in Washington D.C. and its key priorities are reforms in healthcare, education and energy. Already, over $20 billion in economic stimulus has been earmarked for healthcare.
Many challenges abound in the current healthcare system. Since 1994, the cost per person of American health care has more than doubled, with an annual growth rate regularly more than twice that of inflation. Fueled by rising costs of prescription drugs, inefficient outpatient care, expensive and unnecessary medical procedures, and ballooning insurance premiums, these costs are a burden on state and federal governments, businesses, and families. It is clear that reform is needed.
Post marketing surveillance plays a critical role. Adverse events caused by medicines add significant costs to the healthcare system. The U.S. Food and Drug Administration (FDA) has come under increased scrutiny for safety issues associated with approved drugs. The FDA requires drug manufacturers to do extensive safety and efficacy testing of proposed new medications during the approval process. However, after FDA approval, there are concerns that the current post marketing reporting systems fail to:
- Detect drug safety risks and adverse events (AEs) in a timely fashion
- Monitor drug safety in populations that were not included in the drug approval process (e.g., children, pregnant women, and the elderly)
- Identify and contain AEs resulting from off-label medication use
In response to criticisms that the FDA has not been able to ensure post marketing drug safety at acceptable levels, the FDA has responded with increased drug therapy rejection rates. The investments made in these therapies are placed at risk and may never be recouped, driving up the cost of drugs that do make it through the FDA approval process.
To address this vicious cycle, the Veterans Health Administration (VHA) Patient Safety Center of Inquiry (PSCI) in Tampa, Florida has determined, by undertaking a series of proactive medication safety surveillance studies, that the use of large-scale national datasets allows researchers to conduct more sophisticated epidemiologic studies to better inform clinical decision-making. Also, it was found that a proactive medication safety surveillance system can be used on a national level to identify adverse outcomes and events in different settings of care that are associated with selected medications.
Ntrypoint Media aims to gather the world’s life experiences as a means to promote social change in healthcare. Ntrypoint Media is different because we provide social change media through a brand of “personal lifestyle records,” capable of converting social networkers into change agents by recording not only health information but complete experiences about how they live, work and play in any setting. Active contributors who accumulate “social credits” are rewarded with free or low-cost products and services donated by our exclusive network of for-profit and non-profit partners.